Anxiety disorder

The FDA ( U.S. Food and Drug Administration ) has approved Siliq ( Brodalumab ) to treat adults with moderate-to-severe...


The Food and Drug Administration ( FDA ) has approved Duopa ( Carbidopa and Levodopa ) enteral suspension for the...


A review on the efficacy and the tolerability of Quetiapine ( Seroquel ), either as monotherapy or combination therapy, for...


Deep brain stimulation ( DBS ) has become a well-recognized nonpharmacologic treatment that improves motor symptoms of patients with early...


A transient ischemic attack ( TIA ) involves temporary neurological symptoms but leaves a patient symptom-free. Patients are faced with...


In sickle cell disease ( SCD ), pain is considered chronic if it lasts more than 3 months. People with...


A systematic review and meta-analysis of observational studies has investigated the change in mental health after smoking cessation compared with...


The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease ( HD )...


Roflumilast ( Daxas ) is a phosphodiesterase-type-4 ( PDE4 ) inhibitor used for maintenance treatment of severe chronic obstructive pulmonary...


Although the risk of neuropsychiatric side effects with Mefloquine is well-established, a recent review of the prescribing information has led...


To this date, various treatments have been administered to Fahr’s patients in an attempt to achieve remission or at least...


Anorexia nervosa is characterised by a chronic course that is refractory to treatment in many patients and has one of...


While movement problems are the main symptom of Parkinson's disease, a new study has shown that even early in the...


In 2009, the FDA ( Food and Drug Administration ) issued a black box warning for Varenicline ( Champix; in...


New data have shown the efficacy of Agomelatine ( Valdoxan ) in the treatment of anxiety in depressed patients when...


Many of popular herbal supplements, including St. John's wort, gingko biloba, garlic and even grapefruit juice can pose serious risks...


European Medicines Agency ( EMEA ) has completed a review of Rimonabant ( Acomplia ) after concerns about its psychiatric...


Asenapine ( Saphris ) met the primary endpoint over one year of treatment in an extension study in patients with...


Systemic lupus erythematosus ( SLE ) can affect nearly any part of the body, including the joints, skin, kidneys, heart,...


European Medicines Agency ( EMEA ) has completed a review of Rimonabant ( Acomplia ) after concerns about its psychiatric...